Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Sleep Wake Disorders 1Hot Flashes 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Exercise 126Surveys and Questionnaires 59Standard of Care 59Early Intervention, Educational 55Methods 54Educational Status 53Magnetic Resonance Spectroscopy 50Acupuncture Therapy 48Blood Specimen Collection 46Radiotherapy 39Mammography 39Control Groups 35Counseling 32Therapeutics 30Practice Guidelines as Topic 30Cyclophosphamide 29Biopsy 28Sentinel Lymph Node Biopsy 27Psychiatric Rehabilitation 27Neoadjuvant Therapy 24Yoga 23Mastectomy, Segmental 23Resistance Training 22Interviews as Topic 21Surgical Procedures, Operative 19Palliative Care 19High-Energy Shock Waves 19Trastuzumab 18Doxorubicin 18Cognitive Behavioral Therapy 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Venlafaxine Hydrochloride × Breast × Clear all
NCT00084669 2010-04-28

Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer

Massachusetts General Hospital

Phase NA Completed
119 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Sleep Wake Disorders, Carcinoma, Lobular, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡